These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 33726816)
1. Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients. Stranneheim H; Lagerstedt-Robinson K; Magnusson M; Kvarnung M; Nilsson D; Lesko N; Engvall M; Anderlid BM; Arnell H; Johansson CB; Barbaro M; Björck E; Bruhn H; Eisfeldt J; Freyer C; Grigelioniene G; Gustavsson P; Hammarsjö A; Hellström-Pigg M; Iwarsson E; Jemt A; Laaksonen M; Enoksson SL; Malmgren H; Naess K; Nordenskjöld M; Oscarson M; Pettersson M; Rasi C; Rosenbaum A; Sahlin E; Sardh E; Stödberg T; Tesi B; Tham E; Thonberg H; Töhönen V; von Döbeln U; Vassiliou D; Vonlanthen S; Wikström AC; Wincent J; Winqvist O; Wredenberg A; Ygberg S; Zetterström RH; Marits P; Soller MJ; Nordgren A; Wirta V; Lindstrand A; Wedell A Genome Med; 2021 Mar; 13(1):40. PubMed ID: 33726816 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and clinical utility of whole genome sequencing in a cohort of undiagnosed Chinese families with rare diseases. Liu HY; Zhou L; Zheng MY; Huang J; Wan S; Zhu A; Zhang M; Dong A; Hou L; Li J; Xu H; Lu B; Lu W; Liu P; Lu Y Sci Rep; 2019 Dec; 9(1):19365. PubMed ID: 31852928 [TBL] [Abstract][Full Text] [Related]
3. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability. Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722 [TBL] [Abstract][Full Text] [Related]
12. Artificial intelligence enables comprehensive genome interpretation and nomination of candidate diagnoses for rare genetic diseases. De La Vega FM; Chowdhury S; Moore B; Frise E; McCarthy J; Hernandez EJ; Wong T; James K; Guidugli L; Agrawal PB; Genetti CA; Brownstein CA; Beggs AH; Löscher BS; Franke A; Boone B; Levy SE; Õunap K; Pajusalu S; Huentelman M; Ramsey K; Naymik M; Narayanan V; Veeraraghavan N; Billings P; Reese MG; Yandell M; Kingsmore SF Genome Med; 2021 Oct; 13(1):153. PubMed ID: 34645491 [TBL] [Abstract][Full Text] [Related]
13. Efficient detection of chromosome imbalances and single nucleotide variants using targeted sequencing in the clinical setting. Villela D; Costa SS; Vianna-Morgante AM; Krepischi ACV; Rosenberg C Eur J Med Genet; 2017 Dec; 60(12):667-674. PubMed ID: 28882788 [TBL] [Abstract][Full Text] [Related]
14. Genome sequencing as a generic diagnostic strategy for rare disease. Schobers G; Derks R; den Ouden A; Swinkels H; van Reeuwijk J; Bosgoed E; Lugtenberg D; Sun SM; Corominas Galbany J; Weiss M; Blok MJ; Olde Keizer RACM; Hofste T; Hellebrekers D; de Leeuw N; Stegmann A; Kamsteeg EJ; Paulussen ADC; Ligtenberg MJL; Bradley XZ; Peden J; Gutierrez A; Pullen A; Payne T; Gilissen C; van den Wijngaard A; Brunner HG; Nelen M; Yntema HG; Vissers LELM Genome Med; 2024 Feb; 16(1):32. PubMed ID: 38355605 [TBL] [Abstract][Full Text] [Related]